353 related articles for article (PubMed ID: 11229610)
21. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
[TBL] [Abstract][Full Text] [Related]
22. Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system.
Passlick-Deetjen J; Lage C
Perit Dial Int; 2000; 20 Suppl 2():S42-7. PubMed ID: 10911642
[No Abstract] [Full Text] [Related]
23. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
24. Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats.
Ikehara O; Nishimura H; Naito T; Higuchi C; Sanaka T
Nephron Exp Nephrol; 2005; 100(1):e30-9. PubMed ID: 15731567
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.
Dratwa M; Wilkie M; Ryckelynck JP; ter Wee PM; Rutherford P; Michel C; Hopwood A; Curtis L; Denys N; Divino Filho JC; Faict D;
Kidney Int Suppl; 2003 Dec; (88):S105-13. PubMed ID: 14870884
[TBL] [Abstract][Full Text] [Related]
26. Effects of bicarbonate dialysis solution on peritoneal transport in rats.
Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ
Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866
[TBL] [Abstract][Full Text] [Related]
27. Daily exposure to dialysis fluid results in changes in peritoneal transport.
Wang T; Qureshi AR; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1997; 17(4):379-86. PubMed ID: 9284466
[TBL] [Abstract][Full Text] [Related]
28. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
[TBL] [Abstract][Full Text] [Related]
29. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
[TBL] [Abstract][Full Text] [Related]
30. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal accumulation of AGE and peritoneal membrane permeability.
Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells.
Plum J; Razeghi P; Lordnejad RM; Perniok A; Fleisch M; Fusshöller A; Schneider M; Grabensee B
Am J Kidney Dis; 2001 Oct; 38(4):867-75. PubMed ID: 11576893
[TBL] [Abstract][Full Text] [Related]
36. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
[TBL] [Abstract][Full Text] [Related]
37. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
38. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?
Duman S; Günal AI; Sen S; Asçi G; Ozkahya M; Terzioglu E; Akçiçek F; Atabay G
Perit Dial Int; 2001; 21(2):219-24. PubMed ID: 11330572
[TBL] [Abstract][Full Text] [Related]
39. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ
J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248
[TBL] [Abstract][Full Text] [Related]
40. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
